BenzingaOctober 12, 2026 at 5:40 AM NY15 Days Ago
UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26
UBS analyst Alice Nettleton initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Neutral rating and announces Price Target of $26.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
